Morphea in a patient undergoing treatment with ustekinumab

Alexa B Steuer; Erik Peterson; Kristen Lo Sicco; Andrew G Franks Jr

doi:10.1016/j.jdcr.2019.05.008

Morphea in a patient undergoing treatment with ustekinumab

JAAD Case Rep. 2019 Jun 26;5(7):590-592. doi: 10.1016/j.jdcr.2019.05.008. eCollection 2019 Jul.

Authors

Alexa B Steuer¹, Erik Peterson¹, Kristen Lo Sicco¹, Andrew G Franks Jr^{1

2}

Affiliations

¹ The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York.
² Division of Rheumatology, Department of Medicine, New York University School of Medicine, New York, New York.

No abstract available

Keywords: IL, interleukin; Th17, T-helper 17; UC, ulcerative colitis; drug reaction; localized scleroderma; medication-induced morphea; morphea; ustekinumab.

Publication types

Case Reports